Fool me thrice: FDA blasts Chinese API maker for 'misleading' investigators, making up testing records
Fool me thrice: FDA blasts Chinese API maker for 'misleading' investigators, making up testing records fkansteiner Mon, 02/12/2024 - 14:29
Fool me thrice: FDA blasts Chinese API maker for 'misleading' investigators, making up testing records fkansteiner Mon, 02/12/2024 - 14:29
Gritstone's BARDA-funded COVID vaccine faces manufacturing-related trial delay zbecker Mon, 02/12/2024 - 10:58
In stunning reversal, Takeda snags FDA approval for once-snubbed Eohilia after ‘significant grassroots support’ aliu Mon, 02/12/2024 - 10:52
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule kdunleavy Mon, 02/12/2024 - 10:20
PTC's Emflaza to face generics this month after Aurobindo's final FDA nod esagonowsky Mon, 02/12/2024 - 09:49
After rejection, FDA re-accepts Xspray's application for would-be rival to BMS' Sprycel fkansteiner Mon, 02/12/2024 - 09:33